Acute myeloid leukemia (AML) Clinical Trials in Salt Lake City, UT
As of August 2026, 12 paid clinical trials are recruiting for Acute myeloid leukemia (AML) in Salt Lake City, Utah. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Salt Lake City
Filter results
12 clinical trials for Acute myeloid leukemia (AML)
·Clear filters·MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Top Research Study Locations in Salt Lake City
Researchers run research studies in Salt Lake City, UT at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Utah | Acute Myeloid Leukemia, Cancer, Heart Diseases | 211 |
| Huntsman Cancer Institute/University of Utah | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 72 |
| Primary Children's Hospital | Neuroblastoma, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia | 60 |
| Huntsman Cancer Institute | Multiple Myeloma, Colorectal Cancer, Endometrial Cancer | 59 |
| Huntsman Cancer Institute, University of Utah | Advanced Solid Tumor, Breast Cancer, HIV Infection | 34 |
| University of Utah Health | Heart Failure, Interstitial Lung Disease, Progressive Pulmonary Fibrosis | 28 |
| Huntsman Cancer Institute at University of Utah | Gynecologic Cancer, Breast Cancer, Metastatic Castration-resistant Prostate Cancer | 22 |
| University of Utah Hospital | Cardiovascular Diseases, Abdominal Aortic Aneurysm, Cirrhosis | 21 |
| University of Utah Sugarhouse Health Center | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 16 |
| VA Salt Lake City Health Care System, Salt Lake City, UT | Alcohol Use Disorder, Alcohol Use Disorder (AUD), Atherosclerosis | 16 |
| LDS Hospital | ANCA Associated Vasculitis (AAV), Carbon Monoxide Poisoning, Cardiovascular Diseases | 14 |
| Huntsman Cancer Institute at the University of Utah | Multiple Myeloma, Non-Hodgkin Lymphoma, Plasma Cell Leukemia | 14 |
| Utah Cancer Specialists | Colorectal Cancer, Multiple Myeloma, NSCLC | 12 |
| The University of Utah | Bowel; Stricture, Cardiovascular Disease and Lipoprotein(a), Cerebral Palsy | 11 |
| University of Utah Huntsman Cancer Institute | Advanced Melanoma, Breast Cancer, ARID1A Gene Mutation | 11 |
| Intermountain Healthcare | Large B-cell Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma | 10 |
| University of Utah Orthopaedic Center | Acetabular Fracture, Chronic Low-back Pain, Chronic Pain | 8 |
| University of Utah - Huntsman Cancer Institute | Advanced Solid Tumor, Bladder Cancer, Breast Cancer | 7 |
| University of Utah Orthopedics | Ankle Injuries, Cervical Myelopathy, Early Mobilization | 7 |
| Intermountain Health | Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Ovarian Carcinoma | 6 |
| St. Mark's Hospital | Persistent Atrial Fibrillation, AV Block, Atrial Fibrillation | 6 |
| The Eye Institute of Utah | Anterior Segment of Eye, Aphakia, Astigmatism | 6 |
| Clinical Trial Site | Acute Hepatic Porphyria, Hypophosphatasia, Prosthetic-joint Infection | 5 |
| GSK Investigational Site | HIV Infections, Gastrointestinal Neoplasms, Hypereosinophilic Syndrome | 5 |
| George E Wahlen Department of Veterans Affairs Medical Center | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 5 |
Active & Upcoming Studies in Salt Lake City (2026)
Recruiting trials in Salt Lake City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (299 active studies)
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma · Phase 3 · AbbVie
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
Neurology & pain (74 active studies)
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease · Phase 4 · VA Office of Research and Development
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cardiovascular (61 active studies)
- Gestational Hypertension and Preeclampsia Blood Pressure (BP) Treatment Goals Less Than 140/90 vs. Less Than 160/110 mmHg: The GOALPOST Trial · Phase 3 · The George Washington University Biostatistics Center
- BOdygUardian MOnitoriNg for ReCurrencE of AF · Heart Rhythm Clinical and Research Solutions, LLC
Diabetes & metabolic (33 active studies)
- Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah) · University of Utah
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
Eye & vision (23 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA). · University of Utah
Pediatric (19 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Mental health & behavior (18 active studies)
- LLM Intervention for Tobacco in Underserved Populations (LIFT-UP) · University of Utah
- Interprofessional Simulation Program for Clinical Resilience and Empathy: Project INSPIRE · University of Utah
Vaccines (7 active studies)
HIV / STI (5 active studies)
- A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed · Phase 3 · ViiV Healthcare
- Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma · Phase 1 · AIDS Malignancy Consortium
Common conditions studied in Salt Lake City
- Breast Cancer (20 active studies)
- Acute Myeloid Leukemia (13 active studies)
- Multiple Myeloma (13 active studies)
- Advanced Solid Tumor (12 active studies)
- Obesity (11 active studies)
- Heart Failure (10 active studies)
Leading research sponsors in Salt Lake City
- University of Utah
- National Cancer Institute (NCI)
- Novartis Pharmaceuticals
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Salt Lake City?
There are approximately 943 recruiting clinical trials in Salt Lake City, Utah listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Salt Lake City pay participants?
Most recruiting trials in Salt Lake City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Salt Lake City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Salt Lake City?
The most common conditions under active study in Salt Lake City include Breast Cancer (20), Acute Myeloid Leukemia (13), Multiple Myeloma (13), Advanced Solid Tumor (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Salt Lake City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Salt Lake City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Salt Lake City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Salt Lake City?
Recruiting research sites in Salt Lake City include University of Utah, Huntsman Cancer Institute/University of Utah, Primary Children's Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Salt Lake City right now?
The largest active categories in Salt Lake City are Cancer & tumors (299), Neurology & pain (74), Cardiovascular (61). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.